Peregrine Pharmaceuticals (NASDAQ:PPHM)

CAPS Rating: 1 out of 5

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

Recs

0
Player Avatar mpagnotta (80.55) Submitted: 10/2/2012 11:02:03 AM : Outperform Start Price: $0.84 PPHM Score: -9.10

lookin for a bit of a turnaround at this point

Featured Broker Partners


Advertisement